Key result
Myocardial fibrosis, identified via late gadolinium enhancement or serum markers, serves as a risk stratifier for sudden arrhythmic death and ventricular arrhythmias.
Key points are not available for this paper at this time.
May support fibrosis-guided arrhythmic risk stratification; leaves open need for prospective validation before practice change.
Keywords:: afterpotentiallate gadoliniummyocardial fibrosisre-entryserum markers of fibrosis enhancementsudden cardiac deathventricular arrhythmia
No takes yet. Share an insight, caveat, or question.
Sovari et al. (2011) studied this question. Myocardial fibrosis, identified via late gadolinium enhancement or serum markers, serves as a risk stratifier for sudden arrhythmic death and ventricular arrhythmias.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: